STOCK TITAN

Freightos CEO sells 1,535 shares at $0.89

The CEO's reported sale covered tax liability tied to RSU vesting, while the same report lists three option exercise prices.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Freightos Ltd CEO Manrique de Lara Pablo Pinillos sold 1,535 ordinary shares at $0.89 per share on October 1, 2026 to cover tax liability from vesting restricted share units (RSUs). No Rule 10b5-1 plan is reported. The company also lists direct stock options covering 33,333 ordinary shares at a $5 exercise price, 33,333 at $10, and 33,334 at $15; all expire March 16, 2033.

Insider Pinillos Manrique de Lara Pablo
Role CEO
Sold 1,535 shs ($1K)
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 1,535 $0.89 $1K
holding Stock Option (right to buy) F3 -- -- --
holding Stock Option (right to buy) F3 -- -- --
holding Stock Option (right to buy) F3 -- -- --
holding Ordinary Shares F3 -- -- --
holding Ordinary Shares F3, F4 -- -- --
holding Ordinary Shares F3, F5 -- -- --
holding Ordinary Shares F3, F6 -- -- --
Holdings After Transaction: Ordinary Shares — 170,228 shares (Direct); Stock Option (right to buy) — 100,000 contracts (Direct)
Footnotes (6)
  1. F1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
  2. F2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).
  3. F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  4. F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted by the Issuer to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33.33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.33% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
  5. F5. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2028.
  6. F6. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2027.
Ordinary shares sold 1,535 shares October 1, 2026; sale to cover tax liability from RSU vesting
Sale price $0.89 per share October 1, 2026
RSUs originally granted 40,000 RSUs Began vesting April 1, 2025
RSUs vested 33.33% April 1, 2026
Quarterly RSU vesting 8.3325% per quarter Over the following eight quarters
Option exercise price $5 per share Options covering 33,333 ordinary shares; expiration March 16, 2033
Option exercise price $10 per share Options covering 33,333 ordinary shares; expiration March 16, 2033
Option exercise price $15 per share Options covering 33,334 ordinary shares; expiration March 16, 2033
restricted share units financial
"tax liability for vesting of restricted share units"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
tax liability financial
"sale on behalf of the Reporting Person to cover tax liability"
vesting commencement date financial
"three-year anniversary of the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRGO shares did the CEO sell, and at what price?

Manrique de Lara Pablo Pinillos sold 1,535 ordinary shares at $0.89 per share on October 1, 2026, to cover tax liability from vesting RSUs. No Rule 10b5-1 plan is reported.

What was the vesting schedule for the CEO's CRGO RSUs?

The 40,000 RSUs began vesting April 1, 2025. 33.33% vested April 1, 2026; the remaining RSUs vest equally over the following eight quarters at 8.3325% per quarter, with the RSUs, reduced by any for which underlying shares were sold to cover tax liability, fully vesting by April 1, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pinillos Manrique de Lara Pablo

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10,
AVDA. DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares10/01/2026S(1)1,535D$0.8931,126(2)D
Ordinary Shares(3)24,102D
Ordinary Shares(3)40,000(4)D
Ordinary Shares(3)37,500(5)D
Ordinary Shares(3)37,500(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(3)$503/16/202703/16/2033Ordinary Shares33,33333,333D
Stock Option (right to buy)(3)$1003/16/202703/16/2033Ordinary Shares33,33333,333D
Stock Option (right to buy)(3)$1503/16/202703/16/2033Ordinary Shares33,33433,334D
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).
3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted by the Issuer to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33.33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.33% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
5. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2028.
6. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2027.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Max Sitnick, Attorney-in-fact10/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading